Sophiris Bio, Inc.
SPHS
SPHS was delisted on the 11th of March, 2020.
14 hedge funds and large institutions have $998K invested in Sophiris Bio, Inc. in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 8 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
25.91% less ownership
Funds ownership: 36.89% → 10.98% (-26%)
33% less funds holding
Funds holding: 21 → 14 (-7)
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
95% less capital invested
Capital invested by funds: $18.2M → $998K (-$17.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$1.07M |
| 2 |
GCM
Gruss Capital Management
New York
|
+$290K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$143K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$19.7K |
| 5 |
Citigroup
New York
|
+$9.56K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$4.72M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$4.65M |
| 3 |
AG
Artal Group
Luxembourg
|
-$2.93M |
| 4 |
First Manhattan
New York
|
-$1.04M |
| 5 |
First Eagle Investment Management
New York
|
-$733K |
SPHS Hedge Fund Activity: Q4 2014 in Review
14 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q4 2014, worth a combined $998K — down 95% from $18.2M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of SPHS and 2 opened new positions — a net loss of 6 holders — while 2 trimmed existing stakes and 6 added.
The largest buyer was BVF Inc, adding an estimated $1.07M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $4.72M sold.
- 14 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q4 2014, down from 21 in Q3 2014.
- Funds reported $998K of Sophiris Bio, Inc. stock for Q4 2014, down 95% quarter-over-quarter.
- 2 funds opened new Sophiris Bio, Inc. positions in Q4 2014 and 8 closed out, a net change of -6 holders.
- The largest Sophiris Bio, Inc. buyer in Q4 2014 was BVF Inc, an estimated $1.07M added.
- The largest Sophiris Bio, Inc. seller in Q4 2014 was T. Rowe Price Associates, an estimated $4.72M sold.
Based on aggregated 13F filings for Q4 2014.